Navigation Links
BioMedix™ Announces John Martin, MD, FACS, as Medical Director
Date:6/16/2011

SAINT PAUL, Minn., June 16, 2011 /PRNewswire/ -- BioMedix™, a health IT company focused on improving lives through integrated medical devices and software, announces the appointment of John Martin, MD, FACS, as Medical Director. A respected researcher and author, Dr. Martin is one of the only board certified Vascular Surgeons in the nation who is also the CEO of a major cardiology practice. Under Dr. Martin's leadership as Medical Director of Heart and Vascular Services and Director of Surgical Quality, Anne Arundel Medical Center (AAMC) has become a nationally recognized facility for the treatment of vascular disease. Dr. Martin has made a formidable contribution to our nation's preventive healthcare movement and will draw from his extensive expertise to provide leadership and guidance for BioMedix™ company initiatives.

"BioMedix™ continues to make a difference with its innovative products—BioMedix™ technology offers a platform for providers to collaborate to find and treat more patients with vascular disease," said Dr. Martin, "I am excited to join an organization that has long been dedicated to promoting early detection and prevention of cardiovascular events."

Joining the Anne Arundel Medical Center medical staff in 1999, Dr. Martin has served on various hospital committees, including the Strategic Planning Committee of the Board of Trustees. Dr. Martin has developed training, education and multiple research initiatives for AAMC, as well as a dedicated vascular patient unit. In 2000, he co-founded the Dare to C.A.R.E. Foundation, a nonprofit organization dedicated to informing the community about the threat and treatment of cardiovascular disease, providing free cardiovascular screenings to more than 30,000 individuals to date.

"The clinical experience and knowledge of vascular health that Dr. Martin brings to BioMedix™ will strengthen our continuing mission of advancing technology-enabled collaborative care," said John Romans, BioMedix™ President and CEO. "We are very pleased to have a medical professional of his caliber join our team."

Dr. Martin received his BS from the University of Texas at San Antonio. He then completed medical school, his residency in surgery and a fellowship in peripheral vascular surgery at the University of Texas Southwestern Medical Center in Dallas. He is board certified in vascular surgery. In his new role, Dr. Martin will be overseeing care improvement initiatives, research agendas and medical policy development for BioMedix™ medical devices and collaborative care platforms.

About BioMedix™

BioMedix™ is a leader in Health Information Technology (HIT) software, products and services that connect Podiatric Physicians, Primary Care Physicians, vascular labs, vascular specialists, hospitals and healthcare systems in a continuum of collaborative care. We provide the only integrated suite of hardware, software and online services designed to cost-effectively detect vascular disease. Our award-winning suite of medical devices, advanced practice management and Electronic Health Record (EHR) software and web-based solutions give providers a more complete view of patient care. For more information about BioMedix™ products, call 877-854-0014 or log on to www.BioMedix.com.


'/>"/>
SOURCE BioMedix
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMedix™ Now Exclusive Industry Distributor of the APMA Coding Resource Center
2. International Drug & Explosives Detection Company IDenta Corp. Announces New Representative in Japan
3. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
4. American Medical Systems Announces Large-Scale, Physician-Led Registry of Penile Implants
5. Cordis Announces Discontinuation of NEVO™ Sirolimus-Eluting Coronary Stent
6. Endologix Announces FDA Approval of AFX™ Endovascular AAA System
7. Fuisz Announces Issuance of Patent Concerning Product Supplier Database Sharing With an On-Line Vendor
8. Generex Announces Appointment of CEO for Post-Spinout Antigen Express
9. Perrigo Announces Launch of the Generic Version of Nasacort® AQ
10. Masimo Announces Rainbow Agreement with Philips
11. Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Australia Glaucoma ... GlobalData,s new report, "Australia Glaucoma Surgery Devices ... on the Australia Glaucoma Surgery Devices market. The ... volume (in units) and average prices (USD) within ... report also provides company shares and distribution shares ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... poised to grow in 2017-2023. Various reasons for growth ... obese population, higher incidences of chronic diseases, high recovery ... mobility aid services. Medical lifting sling refers to ... with limited mobility. These slings connect to the lift ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... Islandia, NY (PRWEB) , ... December 08, 2016 ... ... company, is pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture ... published in JMIR Medical Informatics . , Results of the comparative usability ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Center has been recognized for adherence to the highest standards of trauma, ... accreditation organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among ...
(Date:12/8/2016)... ... 2016 , ... Vida Health, the digital health platform that pairs ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect ... consumers who are managing chronic conditions or simply want to improve their ...
Breaking Medicine News(10 mins):